Vaneck Net Asset

BBH -  USA Etf  

USD 196.16  1.71  0.86%

Vaneck Biotech ETF fundamentals help investors to digest information that contributes to Vaneck Biotech's financial success or failures. It also enables traders to predict the movement of Vaneck Etf. This fundamental analysis module provides a way for investors to measures Vaneck Biotech's intrinsic value by examining all of its available economic and financial indicators and drivers, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Vaneck Biotech etf. Please note, this module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Vaneck Net Asset 

 
Refresh

Vaneck Net Asset Analysis

Vaneck Biotech's Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Net Asset 
 = 
Current Market Value 
Current Liabilities 
More About Net Asset | All Equity Analysis

Current Vaneck Biotech Net Asset

    
  574.36 M  
Most of Vaneck Biotech's fundamental indicators, such as Net Asset, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Vaneck Biotech ETF is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Compare to competition

Vaneck Biotech Net Asset Component Assessment

Based on the recorded statements, Vaneck Biotech ETF has a Net Asset of 574.36 M. This is 7.31% higher than that of the VanEck family and 39.86% higher than that of the Health category. The net asset for all United States etfs is 74.93% higher than that of the company.

Vaneck Biotech Institutional Holders

Institutional Holdings refers to the ownership stake in Vaneck Biotech that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of Vaneck Biotech's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing Vaneck Biotech's value.
Security TypeSharesValue
Kestra Advisory Services LlcFund Units24.9 KM

Fund Asset Allocation for Vaneck Biotech

The fund invests 99.99% of asset under management in tradable equity instruments, with the rest of investments concentrated in various types of exotic instruments.
 Value 
      Instrument Type 

Vaneck Fundamentals

About Vaneck Biotech Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Vaneck Biotech ETF's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Vaneck Biotech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Vaneck Biotech ETF based on its fundamental data. In general, a quantitative approach, as applied to this etf, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index. Biotech Vaneck is traded on NYSEArca Exchange in the United States.

Be your own money manager

Our tools can tell you how much better you can do entering a position in Vaneck Biotech without increasing your portfolio risk or giving up expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate.risk-adjusted returns of your individual positions relative to your overall portfolio.

Did you try this?

Run Stock Screener Now

   

Stock Screener

Find equities using custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
All  Next Launch Module

Pair Trading with Vaneck Biotech

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vaneck Biotech position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaneck Biotech will appreciate offsetting losses from the drop in the long position's value.

Vaneck Biotech Pair Correlation

Equities Pair Trading Analysis

Correlation analysis and pair trading evaluation for Vaneck Biotech and US Medical Devices. Pair trading can be used as a hedging technique within a particular sector or industry or even over random equities to generate better risk-adjusted return
Run Pair Correlation  
Continue to Vaneck Biotech Piotroski F Score and Vaneck Biotech Altman Z Score analysis. Note that the Vaneck Biotech ETF information on this page should be used as a complementary analysis to other Vaneck Biotech's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Portfolio Diagnostics module to use generated alerts and portfolio events aggregator to diagnose current holdings.

Complementary Tools for Vaneck Etf analysis

When running Vaneck Biotech ETF price analysis, check to measure Vaneck Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaneck Biotech is operating at the current time. Most of Vaneck Biotech's value examination focuses on studying past and present price action to predict the probability of Vaneck Biotech's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Vaneck Biotech's price. Additionally, you may evaluate how the addition of Vaneck Biotech to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Go
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Go
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Go
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
The market value of Vaneck Biotech ETF is measured differently than its book value, which is the value of Vaneck that is recorded on the company's balance sheet. Investors also form their own opinion of Vaneck Biotech's value that differs from its market value or its book value, called intrinsic value, which is Vaneck Biotech's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vaneck Biotech's market value can be influenced by many factors that don't directly affect Vaneck Biotech ETF underlying business (such as pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Vaneck Biotech's value and its price as these two are different measures arrived at by different means. Investors typically determine Vaneck Biotech value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vaneck Biotech's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.